The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
10 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $7,777,001 in first-year total cost, median $780,792.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RTRB-F (A1)]10
Most frequent institutions
- DANA-FARBER CANCER INST2
- BAYLOR COLLEGE OF MEDICINE1
- CHILDREN'S RESEARCH INSTITUTE1
- H. LEE MOFFITT CANCER CTR & RES INST1
- LA JOLLA INSTITUTE FOR IMMUNOLOGY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers1U01DE028227-01 | GUTKIND, JORGE SILVIORAO, ANJANASCHOENBERGER, STEPHEN PHILIP | LA JOLLA INSTITUTE FOR IMMUNOLOGY, CA | $879,388 | ZCA1 |
| 2018 | Molecular and immune drivers of immunotherapy responsiveness in prostate cancer1U01CA233100-01 | FONG, LAWRENCEVAN ALLEN, ELIEZER M | DANA-FARBER CANCER INST, MA | $841,459 | ZCA1 |
| 2018 | MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies1U01CA233084-01 | KUFE, DONALD W.WONG, KWOK KIN | DANA-FARBER CANCER INST, MA | $829,650 | ZCA1 |
| 2018 | Targeting the immunosuppressive tumor microenvironment to enhance efficacy of radiotherapy and immuno-radiotherapy for oral cancer1U01DE028233-01 | ANNAPRAGADA, ANANTH VSIKORA, ANDREW | BAYLOR COLLEGE OF MEDICINE, TX | $804,594 | ZCA1 |
| 2018 | B cell-dependent anti-tumor immunity in ovarian cancer1U01CA232758-01 | CONEJO-GARCIA, JOSE R | H. LEE MOFFITT CANCER CTR & RES INST, FL | $781,585 | ZCA1 |
| 2018 | Targeting alternative splicing for TCR discovery in small cell carcinomas1U01CA233074-01 | CROOKS, GAY MWITTE, OWEN N.XING, YI | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $779,998 | ZCA1 |
| 2018 | Immunomodulation of the Tumor Microenvironment with Molecular Targeted Radiotherapy to Facilitate an Adaptive Anti-Tumor Immune Response to Combined Modality Immunotherapies1U01CA233102-01 | MORRIS, ZACHARY SCOTTWEICHERT, JAMEY P | UNIVERSITY OF WISCONSIN-MADISON, WI | $765,000 | ZCA1 |
| 2018 | Immunosuppressive mechanisms responsible for development of non-viral liver cancer and control of its response to immune checkpoint inhibitors1U01AA027681-01 | EL-KHOUEIRY, ANTHONY BOUTROSKARIN, MICHAELSHALAPOUR, SHABNAMTSUKAMOTO, HIDEKAZU | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $737,531 | ZCA1 |
| 2018 | N-glycosylation and Immunotherapy for cancer1U01CA233078-01 | DEMETRIOU, MICHAEL | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $683,540 | ZCA1 |
| 2018 | Enhancing cell therapy for brain tumors1U01CA239258-01 | BOLLARD, CATHERINE M.CRUZ, CONRAD RUSSELL YOUNGJONES, RICHARD JSAVOLDO, BARBARA | CHILDREN'S RESEARCH INSTITUTE, DC | $674,256 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.